AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	216,383	193,986	215,159	133,010	81,183	63,886
Market Cap Growth	5.86%	-9.84%	61.76%	63.84%	27.07%	-15.11%
Enterprise Value	213,003	190,335	210,362	127,861	76,552	60,484
Last Close Price	8655.30	7759.45	8577.01	5284.39	3211.62	2520.50
PE Ratio	115.39	103.45	185.90	82.35	81.76	103.71
PS Ratio	9.39	8.42	12.54	10.27	8.09	7.93
PB Ratio	24.79	22.23	27.93	18.68	13.79	12.49
P/TBV Ratio	24.79	22.23	27.95	18.74	13.79	12.49
P/FCF Ratio	-	-	338.25	777.38	163.12	70.07
P/OCF Ratio	-	-	329.19	477.25	139.27	63.38
EV/Sales Ratio	9.24	8.26	12.26	9.87	7.63	7.51
EV/EBITDA Ratio	73.32	65.52	84.67	69.81	47.45	73.16
EV/EBIT Ratio	81.32	72.66	97.93	74.58	51.43	87.20
EV/FCF Ratio	-1275.47	-	330.71	747.29	153.81	66.33
Debt / Equity Ratio	0.13	0.13	0.05	0.01	0.01	0.02
Debt / EBITDA Ratio	0.38	0.38	0.14	0.02	0.04	0.10
Debt / FCF Ratio	-	-	0.56	0.27	0.14	0.10
Net Debt / Equity Ratio	-0.39	-0.39	-0.65	-0.70	-0.84	-0.86
Net Debt / EBITDA Ratio	-1.16	-1.16	-2.01	-2.73	-3.06	-5.32
Net Debt / FCF Ratio	20.24	20.24	-7.87	-29.28	-9.91	-4.82
Asset Turnover	1.31	1.31	1.32	1.26	1.09	0.99
Inventory Turnover	1.75	1.75	2.50	2.87	2.22	2.11
Quick Ratio	0.68	0.68	1.05	1.89	1.61	1.64
Current Ratio	1.77	1.77	1.91	2.61	2.18	2.12
Return on Equity (ROE)	22.82%	22.82%	15.62%	24.84%	18.05%	12.73%
Return on Assets (ROA)	9.34%	9.34%	10.34%	10.39%	10.11%	5.32%
Return on Invested Capital (ROIC)	40.21%	48.40%	66.13%	82.29%	131.87%	54.86%
Return on Capital Employed (ROCE)	26.00%	26.00%	26.40%	23.80%	24.80%	13.20%
Earnings Yield	0.87%	0.97%	0.54%	1.21%	1.22%	0.96%
FCF Yield	-0.08%	-0.09%	0.30%	0.13%	0.61%	1.43%
Dividend Yield	0.36%	-	0.37%	0.45%	0.50%	0.40%
Payout Ratio	42.66%	42.66%	51.84%	24.77%	20.14%	8.12%
Buyback Yield / Dilution	0.00%	0.00%	-	-	-	-
Total Shareholder Return	0.37%	0.00%	0.37%	0.45%	0.50%	0.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.